GSCG has 36 stem cell centers in 27 countries globally, plus the Adimarket which sells products and recently outfits a medical center exclusively. This adds another revenue stream in addition to the work of its centers administering stem cell therapies and training medical professionals, and another way this company can scale and expand within the industry. There are a lot of facets to take in when assessing the potential this company has in a hot, growing sector.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.